Molecular Pathogenesis of Hepatocellular CarcinomaCORNELLA, Helena; ALSINET, Clara; VILLANUEVA, Augusto et al.Alcoholism, clinical and experimental research. 2011, Vol 35, Num 5, pp 821-825, issn 0145-6008, 5 p.Conference Paper

Gene Signatures in the Management of Hepatocellular CarcinomaHOSHIDA, Yujin; MOEINI, Agrin; ALSINET, Clara et al.Seminars in oncology. 2012, Vol 39, Num 4, pp 473-485, issn 0093-7754, 13 p.Article

Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivoNEWELL, Pippa; TOFFANIN, Sara; YEA, Steven et al.Journal of hepatology. 2009, Vol 51, Num 4, pp 725-733, issn 0168-8278, 9 p.Article

Combination therapy for hepatocellular carcinoma: Additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenibLACHENMAYER, Anja; TOFFANIN, Sara; FRIEDMAN, Scott L et al.Journal of hepatology. 2012, Vol 56, Num 6, pp 1343-1350, issn 0168-8278, 8 p.Article

Wnt-Pathway Activation in Two Molecular Classes of Hepatocellular Carcinoma and Experimental Modulation by SorafenibLACHENMAYER, Anja; ALSINET, Clara; BARRETINA, Jordi et al.Clinical cancer research (Print). 2012, Vol 18, Num 18, pp 4997-5007, issn 1078-0432, 11 p.Article

IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockageTOVAR, Victoria; ALSINET, Clara; CABELLOS, Laia et al.Journal of hepatology. 2010, Vol 52, Num 4, pp 550-559, issn 0168-8278, 10 p.Article

New Strategies in Hepatocellular Carcinoma: Genomic Prognostic MarkersVILLANUEVA, Augusto; HOSHIDA, Yujin; TOFFANIN, Sara et al.Clinical cancer research (Print). 2010, Vol 16, Num 19, pp 4688-4694, issn 1078-0432, 7 p.Article